(FY)Jun 30, 2023 | (FY)Jun 30, 2022 | |
---|---|---|
Operating cash flow (direct method) | ||
Cash income from operating activities | ||
Cash paid | -123.67%-4.16M | -1.86M |
Payments to suppliers for goods and services | -123.67%-4.16M | ---1.86M |
Direct interest paid | 14.50%-6.54K | ---7.65K |
Operating cash flow | -123.10%-4.17M | ---1.87M |
Investing cash flow | ||
Cash flow from continuing investing activities | -22.80%-2.23M | -1.82M |
Capital expenditure reported | -41.86%-2.05M | ---1.44M |
Net PPE purchase and sale | 16.47%-183.42K | ---219.59K |
Net other investing changes | ---- | ---153.65K |
Cash from discontinued investing activities | ||
Investing cash flow | -22.80%-2.23M | ---1.82M |
Financing cash flow | ||
Cash flow from continuing financing activities | 146.24%5.5M | 2.23M |
Net issuance payments of debt | ---- | ---23.75K |
Net common stock issuance | 143.15%5.52M | --2.27M |
Net other financing activities | -62.91%-23.08K | ---14.17K |
Cash from discontinued financing activities | ||
Financing cash flow | 146.24%5.5M | --2.23M |
Net cash flow | ||
Beginning cash position | -24.99%4.35M | --5.8M |
Current changes in cash | 38.12%-897.3K | ---1.45M |
End cash Position | -20.61%3.46M | --4.35M |
Free cash from | -81.74%-6.41M | ---3.53M |
Accounting Standards | US-GAAP | US-GAAP |
No Data
No Data